Emilia Cantón

Dr. Emilia Cantón


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2011 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
ECEmilia Cantón
Emilia Cantón
JPJavier Pemán
Javier Pemán
Guillermo QuindósGuillermo Quindós
Guillermo Quindós
EEElena Eraso
Elena Eraso
IMIlargi Miranda-Zapico
Ilargi Miranda-Zapico
TGthe FUNGEMYCA Study Group
the FUNGEMYCA Study Group
A 13-month prospective multicenter study including 44 hospitals was carried out to evaluate the epidemiology of Candida parapsilosis complex candidemia in Spain. Susceptibility to amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole, posaconazole, anidulafungin, caspofungin, and micafungin was tested by the microdilution colorimetric method. A total of 364 C. parapsilosis complex isolates were identified by molecular methods: C. parapsilosis (90.7%), Candida orthopsilosis (8.2%), and Candida metapsilosis (1.1%). Most candidemias ( C. parapsilosis , 76.4%; C. orthopsilosis , 70.0%; C. metapsilosis , 100%) were observed in adults. No C. orthopsilosis or C. metapsilosis candidemias occurred in neonates. C. parapsilosis was most frequent in adult intensive care unit (28.8%), surgery (20.9%), and internal medicine (19.7%) departments; and C. orthopsilosis was most frequent in hematology (28.6%), pediatrics (12.0%), and neonatology (11.5%) departments. The geographic distribution of C. orthopsilosis and C. metapsilosis was not uniform. According to CLSI clinical breakpoints, all C. orthopsilosis and C. metapsilosis isolates were susceptible to the nine agents tested. Resistance (MICs > 1 mg/liter) was observed only in C. parapsilosis : amphotericin B, posaconazole, itraconazole, and caspofungin (0.3% each), anidulafungin (1.9%), and micafungin (2.5%). Applying the new species-specific fluconazole and echinocandin breakpoints, the rates of resistance to fluconazole for C. parapsilosis and C. orthopsilosis increased to 4.8% and 0.3%, respectively; conversely, for C. parapsilosis they shifted from 1.9 to 0.6% (anidulafungin) and from 2.5 to 0.6% (micafungin). Our study confirms the different prevalence of C. parapsilosis complex candidemia among age groups: neither C. orthopsilosis nor C. metapsilosis was isolated from neonates; interestingly, C. metapsilosis was isolated only from adults and the elderly. The disparity in antifungal susceptibility among species could be important for therapy.

1 March 2003 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
ECEmilia Cantón
Emilia Cantón
JPJavier Pemán
Javier Pemán
AVAngel Viudes
Angel Viudes
Guillermo QuindósGuillermo Quindós
Guillermo Quindós
MGMiguel Gobernado
Miguel Gobernado
AEAna Espinel-Ingroff
Ana Espinel-Ingroff

1 July 2004 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
ECEmilia Cantón
Emilia Cantón
JPJavier Pemán
Javier Pemán
MGMiguel Gobernado
Miguel Gobernado
AVAngel Viudes
Angel Viudes
AEAna Espinel-Ingroff
Ana Espinel-Ingroff
In a previous study tolerance to amphotericin B (AMB) was found among Candida parapsilosis and C. dubliniensis strains by seeding the whole volumes of wells used for MIC determinations, and minimum fungicidal concentrations (MFC) for non- C. albicans Candida strains were demonstrated to be above the levels safely achievable in serum. As an extension of that study, we performed time-kill assays with 26 blood culture isolates (6 C. albicans , 5 C. parapsilosis , 5 C. krusei , 4 C. glabrata , 3 C. lusitaniae , and 3 C. tropicalis isolates), 3 oropharyngeal C. dubliniensis isolates, 3 AMB-susceptible isolates (ATCC 90028, ATCC 22019, ATCC 6254), and 6 AMB-resistant isolates (ATCC 200955, ATCC 200956, ATCC 200950, ATCC 200951, ATCC 200952, ATCC 200953) using RPMI 1640 medium and 0.12 to 32 μg of AMB per ml and determined the numbers of CFU per milliliter at 0, 2, 4, 8, 12, 24, and 48 h. MFCs and time-kill patterns were species specific (MFCs, ≤1 μg/ml for all C. dubliniensis and C. albicans isolates except AMB-resistant strain ATCC 200955; MFCs, 2 to >16 μg/ml for the other isolates). The times required to reach the fungicidal endpoint (99.9% killing) at four times the MIC were 2 h for C. albicans and C. dubliniensis , 16 h for C. glabrata , 24 h for C. parapsilosis and C. lusitaniae , and ≥40 h for C. tropicalis and C. krusei . The killing rate increased as the AMB concentration was increased up to 2 μg/ml. The highest killing rates were achieved for C. albicans , C. dubliniensis , and C. lusitaniae , while viable C. tropicalis, C. krusei , and C. parapsilosis cells were present after 48 h (MICs, ≤2 μg/ml) when AMB was used at 2 μg/ml. Time-kill curves and MFCs can detect viable cells after 48 h when AMB is used at ≥2 μg/ml. The failure of AMB treatment could be due to its poor killing activity against some species at the concentrations reached in patients' serum.

1 February 2009 in Expert Review of Anti-infective Therapy
Verified
Journal Article
Closed access
ECEmilia Cantón
Emilia Cantón
AEAna Espinel-Ingroff
Ana Espinel-Ingroff
JPJavier Pemán
Javier Pemán
Antifungal susceptibility testing should identify in vitro resistance among a normally susceptible population or should detect the development of resistance during therapy. The Clinical and Laboratory Standards Institute (CLSI; formerly the National Committee for Clinical Laboratory Standards [NCCLS]) has developed reproducible methods for testing the activity of antifungal agents against yeasts (the M27-A3, M27-S3, M44-A and M44-S2 documents) and filamentous fungi (molds; the M38-A2 document). The yeast documents describe both quality control (QC) and interpretative breakpoint parameters for several antifungal agents versus Candida spp. In vitro breakpoints, as well as a QC and reference strain, has been recently described for mold testing. Standard guidelines for testing echinocandins against molds, guidelines for testing dermatophytes, as well as a disk-diffusion method for molds, have been developed recently. However, standard parameters for minimum fungicidal concentration determinations and selection of QC strains and guidelines for testing Malassezia spp. are under development. Breakpoints for Cryptococcus neoformans, dermatophytes and Malassezia spp. versus any antifungal agent and for posaconazole and amphotericin B versus yeasts are not available.

13 August 2003 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
EMEstrella Martín-Mazuelos
Estrella Martín-Mazuelos
JPJavier Pemán
Javier Pemán
AVAnastasio Valverde
Anastasio Valverde
MCMónica Chaves
Mónica Chaves
MSM. Carmen Serrano
M. Carmen Serrano
ECEmilia Cantón
Emilia Cantón
Objective: The evaluation of the Sensititre YeastOne and Etest methods for determining susceptibility to amphotericin B and itraconazole by comparing the MICs obtained by these methods at different times of reading with those of the M38-A broth microdilution method. Methods: Sixty-three clinical isolates of Aspergillus spp. (23 Aspergillus flavus, 24 Aspergillus fumigatus, nine Aspergillus niger, three Aspergillus glaucus, two Aspergillus terreus and two Aspergillus flavipes) were assayed. Two itraconazole-resistant strains (NCPF7100 and 7099) were also included. Results: Itraconazole MICs for the two resistant strains were >4 mg/L by the three methods. The overall agreement (±2 log2) between M38-A (48 h) and colorimetric (48 h) method was 93.4% for amphotericin B and 90.2% for itraconazole. By the Etest, the best agreement with M38-A was obtained when readings were made at 24 h: 88.5% for amphotericin B and 67.2% for itraconazole. Etest MICs were higher for all species except A. niger. Conclusions: The colorimetric method appears to be a suitable alternative procedure for antifungal susceptibility testing of Aspergillus spp. and is able to detect resistance to itraconazole. The range of MICs for amphotericin B by Etest is wider and for some strains is >16 mg/L, suggesting that this method could be useful for detecting resistant strains as occur in yeasts.

1 May 2010 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
ECEmilia Cantón
Emilia Cantón
AEAna Espinel-Ingroff
Ana Espinel-Ingroff
JPJavier Pemán
Javier Pemán
LCLucas del Castillo
Lucas del Castillo
Anidulafungin, micafungin, and caspofungin in vitro activities against Candida metapsilosis , C. orthopsilosis , and C. parapsilosis were evaluated by MICs and time-kill methods. All echinocandins showed lower MICs (mean MICs, 0.05 to 0.71 mg/liter) and the highest killing rates (−0.06 to −0.05 CFU/ml/h) for C. metapsilosis and C. orthopsilosis rather than for C. parapsilosis (mean MICs, 0.59 to 1.68 mg/liter). Micafungin and anidulafungin killing rates were greater than those determined for caspofungin. None of the echinocandins had fungicidal activity against C. parapsilosis .